The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...
A stage 3b rectal cancer diagnosis was unexpected for someone dedicated to health and fitness, leading to a challenging treatment journey. Intensive IMRT radiation and chemotherapy required ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback